|Work hours||Add information|
|About||Celther is focused on targeted and cell therapies, stem cells research (iPS cells), development of research models: primary cancer cell lines.|
Celther Polska is a young and dynamically developing biopharmaceutical enterprise with focus on commercialization of the proprietary research results in the following fields:
• personalizaed therapy: targeted and cell therapies,
• stem cells research: induced pluripotent stem cells (iPS cells) and its derivatives,
• development of research models: primary cancer cell lines,
• biomaterials: wound dressing material.
Moreover, Celther Polska offers a broad range of services for life sciences related industries, such as: cytotoxicity, next generation sequencing, stable and iPS cell line generation or genetic engineering services etc.
Celther Polska Sp. z o.o. was nominated to SYMBOL 2015 award in the category EuroSymbol of Innovation 2015 for "Development of targeted anticancer therapy" project. The Organizer of the Program are "Monitor Biznesu" and "Monitor Rynkowy," supplements to "Rzeczpospolita" and "Gazeta Prawna" newspapers.
Statue of Marshal of Lodz Region for Entrepreneur most effectively using potential of scientists.
3rd prize in the contest for poster presentation during the 5th International Conference on Drug Discovery and Therapy in Dubai.
Commendation from the Polish Agency for Enterprise Development in the category "Innovative project in pharmaceutical/medical branch" for the project entitled "Innovative cellular biodegradable dressing material for chronic wounds and ulcerations".
Finalist in the contest for "The best innovative company" - during the 10th edition of Bioforum in 2011.
Laureate in the contest - Nominees Lodz Offers " Innovative and Creative in Lodz 2010".
Primary cancer cell lines
Human induced pluripotent stem cells (iPS cells)